Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

236
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
236
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

269
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
269
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

421
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
421
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

531
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
531
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

678
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
678
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

730
Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
730

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ITARA research programme: Investigating Integrated Tuberculosis And Respiratory care in Africa using transdisciplinary methods.

BMJ open·2026
Same author

Risk perceptions of high-dose primaquine and tafenoquine among <i>Plasmodium vivax</i> malaria stakeholders in Ethiopia: a qualitative study.

BMJ global health·2026
Same author

Acceptability and feasibility of oral swabs for tuberculosis diagnosis in young children: a qualitative study from Uganda and Peru.

Frontiers in tuberculosis·2026
Same author

Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial.

The Lancet. Infectious diseases·2026
Same author

Reported Tuberculosis Symptoms: An Inadequate Classifier of Disease State.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia.

Malaria journal·2025
Same journal

Lytic bacteriophages active in urine against multi-drug resistant clinically derived Klebsiella pneumoniae causing urinary tract infection.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Time to Recovery from Long COVID: A Longitudinal Analysis of Symptom Duration and Risk Factors Using Accelerated Failure Time Models.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Site matters: extrapulmonary tuberculosis localization patterns and clinical outcomes in the Netherlands,1993-2022.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

When Institutional Transitions Interrupt Prevention: 3HP Tuberculosis Preventive Treatment Continuity in a Paraguayan Prison Cohort.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Cross-neutralization of SARS-CoV-2 BA.3.2.2 lineage by JN.1 mRNA vaccine-induced immunity.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Prevalence and associated factors of severe mpox in Mbarara City, southwestern Uganda, October 2024-May 2025.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
See all related articles

Related Experiment Video

Updated: Oct 20, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.0K

Constructing confidence: User perspectives on AlereLAM testing for tuberculosis.

Muthoni Mwaura1, Nora Engel1

  • 1Department of Health, Ethics & Society; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|September 15, 2021
PubMed
Summary
This summary is machine-generated.

Urine LAM diagnostics like AlereLAM show promise for tuberculosis (TB) in people with HIV (PLHIV), but slow uptake is linked to performance communication and implementation barriers.

Keywords:
LipoarabinomannanPoint-of-care diagnosticsQualitative methodsTB/HIV

More Related Videos

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.3K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.3K

Related Experiment Videos

Last Updated: Oct 20, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.0K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

81.3K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.3K

Area of Science:

  • Medical Diagnostics
  • Infectious Disease Research
  • Public Health

Background:

  • Diagnosing tuberculosis (TB) in people living with HIV (PLHIV) is difficult due to atypical presentations and higher rates of sputum-negative or extrapulmonary disease.
  • Urine LAM (lipids A and M) is a promising biomarker for TB diagnosis in this population.
  • AlereLAM, a WHO-recommended point-of-care (POC) test, remains underutilized.

Purpose of the Study:

  • To explore the perspectives and experiences of healthcare professionals and stakeholders regarding the use of AlereLAM for TB diagnosis in PLHIV.
  • To identify factors influencing the slow uptake of AlereLAM despite its potential benefits.

Main Methods:

  • Conducted 15 semi-structured interviews with diverse healthcare stakeholders in Uganda, Kenya, and South Africa.
  • Explored current TB diagnostic approaches, user experiences, and country-specific policies related to AlereLAM.

Main Results:

  • AlereLAM has value in identifying TB in people with advanced HIV disease, particularly when confidence in the test is established.
  • Challenges to AlereLAM uptake include initial reports of low sensitivity/specificity, restrictive eligibility criteria, and reliance on CD4+ testing.
  • Lack of advocacy and awareness also contributed to slow adoption.

Conclusions:

  • Operationalizing diagnostics, including building confidence in their performance, is crucial for policymakers, implementers, and funders.
  • Successful scale-up of diagnostics like AlereLAM requires addressing implementation science challenges beyond initial test validation.